Reprogramming the tumor microenvironment via TFF3 targeting: a potential novel avenue to boost CAR-T cell therapy in solid tumors

Cancer Gene Therapy 2026

View at publisher
Authors: Arman Rahimi, Ghasem Solgi, Mehrnoush Safarzadeh, Pantea Mohammadi, Mohsen Rastegari‐Pouyani
DOI: 10.1038/s41417-026-01040-9
Cited by: 1
References: 104

Fields of Study & Subjects

Immunotherapy and Immune Responses CAR-T cell therapy research Monoclonal and Polyclonal Antibodies Research

Publication details

Journal / source
Cancer Gene Therapy
Publisher
Springer Science and Business Media LLC
Volume
33
Issue
4
Pages
492–503
Publication date
1 April 2026
Language
EN